2424 Results for "

decrease

" in MedChemExpress (MCE) Product Catalog:
Products (2424)

2424 Results for "decrease" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-B1132
CAS No.: 3485-62-9
Synonyms: Ro 2-3773
Target:  

mAChR

Research Areas:  

Neurological Disease

Clidinium bromide is a quaternary amine antimuscarinic agent. Clidinium bromide may help symptoms of cramping and abdominal/stomach pain by decreasing stomach acid, and slowing the intestines in vivo .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P5521
CAS No.: 3033299-76-9
Target:  

Inhibitory Antibodies

Research Areas:  

Cardiovascular Disease

mLR12 is a Trem1 inhibitory peptide. mLR12 decreases aortic rupture rate in BAPN-induced Thoracic aortic aneurysm and dissection (TAAD) mice model .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-130321
CAS No.: 6919-91-1
Purity:  ≥98.0%
Lauroyl-L-carnitine chloride is an orally active metabolite. Lauroyl-L-carnitine chloride significantly reverses the decrease in its target gene IL-10. Lauroyl-L-carnitine chloride alleviates Crohn' s-like colitis .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B0259
CAS No.: 26807-65-8
Target:  

Potassium Channel

Research Areas:  

Cardiovascular Disease

Indapamide is an orally active sulphonamide diuretic agent, that can reduce blood pressure by decreasing vascular reactivity and peripheral vascular resistance. Indapamide is also can reduce left ventricular hypertrophy .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-135761
CAS No.: 66246-88-6
Purity:  98.91%
Penconazole is a typical triazole fungicide, and mainly applied on apples, grapes, and vegetables to control powdery mildew. Penconazole inhibits sterol biosynthesis in fungi. Penconazole decrease AChE activity in the cerebrum and cerebellum of rats .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-138208
CAS No.: 114014-15-2
Purity:  98.04%
Target:  

Cathepsin SARS-CoV

Research Areas:  

Infection

Z-Phe-Tyr(tBu)-diazomethylketone is a potent cathepsin L inhibitor. Z-Phe-Tyr(tBu)-diazomethylketone mediates reovirus disassembly. Z-Phe-Tyr(tBu)-diazomethylketone decreases viral detection .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-147041
CAS No.: 1978336-95-6
Purity:  98.87%
Synonyms: GB1211
Target:  

Galectin

Research Areas:  

Inflammation/Immunology Cancer

Selvigaltin (GB1211) is an orally active galectin-3 small molecule inhibitor with an IC50 value of 12 nM in rabbits, showing anti-tumor activity. Selvigaltin decreases galectin-3 levels in the liver and reduces biomarkers of liver function (AST, ALT, bilirubin), inflammation (cells foci) and fibrosis (PSR, SHG), as well as decreasing the mRNA and protein expression of several key inflammation and fibrosis biomarkers (IL6, TGFβ3, SNAI2, collagen). Selvigaltin restores T-cell activity and induces less tumors and metastasis .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-13619
CAS No.: 131179-95-8
Purity:  99.94%
Synonyms: RSR13
Target:  

Hemoglobin

Research Areas:  

Infection Cancer

Efaproxiral (RSR13) is a haemoglobin (Hb) synthetic allosteric modifier. Efaproxiral decreases Hb-oxygen (O2) binding affinity and enhances oxygenation of hypoxic tumours during radiation therapy .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-13619A
CAS No.: 170787-99-2
Purity:  99.90%
Synonyms: RSR13 sodium
Target:  

Hemoglobin

Research Areas:  

Infection Cancer

Efaproxiral (RSR13) sodium is a haemoglobin (Hb) synthetic allosteric modifier. Efaproxiral sodium decreases Hb-oxygen (O2) binding affinity and enhances oxygenation of hypoxic tumours during radiation therapy .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-146985
CAS No.: 2418577-51-0
Purity:  99.62%
Target:  

Cathepsin

Research Areas:  

Neurological Disease Cancer

Cathepsin X-IN-1 (compound 25) is a potent Cathepsin X inhibitor with an IC50 of 7.13 µM. Cathepsin X-IN-1 decreases PC-3 cell migration with low cytotoxic .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-119146
CAS No.: 31352-82-6
Synonyms: CI-716 free base
Target:  

Drug Derivative

Research Areas:  

Neurological Disease

Zolazepam (CI-716 free base) is a benzodiazepine derivative with anxiolytic and anticonvulsant properties. Zolazepam combined with Tiletamine causes a decrease in ventilation, resulting in the development of respiratory acidosis. Zolazepam can be used as sedative and muscle relaxants .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N2113
CAS No.: 80508-81-2
Glaucocalyxin B is an ent kaurane diterpenoid isolated from the Chinese traditional medicine Rabdosia japonica with anticancer and antitumor activity; decreases the growth of HL-60 cells with an IC50 of approximately 5.86 μM at 24 h.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-104006
CAS No.: 1069498-96-9
Purity:  99.12%
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

CYM51010 is a biased ligand of μ-opioid receptor – δ-opioid receptor heterodimers with an EC50 of 403 nM. CYM51010 exhibits anti-nociceptive activity similar to morphine but with a decreased levels of tolerance development and withdrawal symptoms .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100775
CAS No.: 1254472-97-3
Purity:  99.78%
Synonyms: Setogepram sodium; PBI-4050 sodium
Fezagepras (Setogepram) sodium acts as an orally active agonist for GPR40 and as an antagonist or inverse agonist for GPR84 . Fezagepras sodium decreases renal, liver and pancreatic fibrosis . Fezagepras sodium exerts anti-fibrotic, anti-inflammatory and anti-proliferative actions .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100775A
CAS No.: 1002101-19-0
Purity:  99.38%
Synonyms: Setogepram; PBI-4050
Fezagepras (Setogepram) acts as an orally active agonist for GPR40 and as an antagonist or inverse agonist for GPR84 . Fezagepras decreases renal, liver and pancreatic fibrosis . Fezagepras exerts anti-fibrotic, anti-inflammatory and anti-proliferative actions .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-120034
CAS No.: 1462267-07-7
Purity:  99.53%
NCGC 607 is a noninhibitory small-molecule chaperone of glucocerebrosidase (GCase). NCGC 607 can increase GCase activity, reduce α-synuclein levels, and decrease glycolipid levels. NCGC 607 can be used in the research of Gaucher disease and Parkinson's disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P3585
CAS No.: 915091-83-7
Epobis, a dendrimeric peptide, is a recombinant form of erythropoietin. Epobis is a potent erythropoietin receptor agonist. Epobis promotes neuritogenesis in primary motoneurons. Epobis decrease TNF release and crosses the blood-brain barrier. Epobis has anti-inflammatory and memory enhancing properties .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-13033
CAS No.: 1269815-17-9
Purity:  98.97%
Synonyms: CDK inhibitor II
Target:  

CDK

Research Areas:  

Endocrinology

CDK-IN-2 is a specific CDK9 inhibitor with an IC50 of less than 8 nM. CDK-IN-2 reduces the phosphorylation level of H3S10. CDK-IN-2 decreases the transition rate of spermatocytes from prophase to metaphase I .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-153728
CAS No.: 2894832-05-2
Purity:  98.74%
Target:  

WDR5

Research Areas:  

Cancer

WM-586 is a covalent WDR5 inhibitor. WM-586 specifically decreases WDR5 and MYC interaction with an IC50 of 101 nM. WM-586 is used in research on a variety of cancers including neuroblastoma, breast cancer, bladder cancer and colorectal cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-15841
CAS No.: 1391712-60-9
Purity:  99.91%
Research Areas:  

Cancer

CEP-37440 is a potent, orally active dual FAK/ALK inhibitor with IC50 values of 2.3 nM and 3.5 nM for FAK and ALK, respectively. CEP-37440 decreases the cell proliferation by blocking the autophosphorylation kinase activity of FAK1 (Tyr 397) .
loading...
    loading...